ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 561,13
1,09%
Dow Jones
39 160,27
0,11%
DAX
18 290,66
0,31%
Brent Oil
86,205
1,29%
Bitcoin
62 948,49
0,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Unicycive Therapeutics Inc (UNCY)

  7. Unicycive Therapeutics Inc (UNCY) Actualités

UNCY

Unicycive Therapeutics (UNCY)

Unicycive Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:UNCY
DateHeureSourceTitreSymboleSociété
01/07/202413h03GlobeNewswire Inc.Unicycive Therapeutics Joins Russell Microcap® IndexNASDAQ:UNCYUnicycive Therapeutics Inc
25/06/202413h30GlobeNewswire Inc.Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical TrialNASDAQ:UNCYUnicycive Therapeutics Inc
28/05/202413h03GlobeNewswire Inc.Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
23/05/202413h03GlobeNewswire Inc.Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
15/05/202413h03GlobeNewswire Inc.Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202422h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202422h16GlobeNewswire Inc.Unicycive Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
13/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UNCYUnicycive Therapeutics Inc
08/05/202422h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:UNCYUnicycive Therapeutics Inc
10/04/202413h03GlobeNewswire Inc.Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
28/03/202421h15GlobeNewswire Inc.Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
25/03/202412h03GlobeNewswire Inc.Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association CongressNASDAQ:UNCYUnicycive Therapeutics Inc
14/03/202412h03GlobeNewswire Inc.Unicycive Announces $50 Million Private PlacementNASDAQ:UNCYUnicycive Therapeutics Inc
13/03/202412h03GlobeNewswire Inc.Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
07/03/202422h12GlobeNewswire Inc.Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
04/03/202413h03GlobeNewswire Inc.Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant PatientsNASDAQ:UNCYUnicycive Therapeutics Inc
14/02/202413h03GlobeNewswire Inc.Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical MeetingNASDAQ:UNCYUnicycive Therapeutics Inc
29/01/202413h03GlobeNewswire Inc.Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT ConferenceNASDAQ:UNCYUnicycive Therapeutics Inc
23/01/202413h03GlobeNewswire Inc.Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming MilestonesNASDAQ:UNCYUnicycive Therapeutics Inc
22/01/202422h27Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:UNCYUnicycive Therapeutics Inc
18/12/202313h03GlobeNewswire Inc.Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on DialysisNASDAQ:UNCYUnicycive Therapeutics Inc
08/12/202322h36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:UNCYUnicycive Therapeutics Inc
29/11/202313h03GlobeNewswire Inc.Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023NASDAQ:UNCYUnicycive Therapeutics Inc
14/11/202322h15GlobeNewswire Inc.Unicycive Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
23/10/202313h03GlobeNewswire Inc.Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)NASDAQ:UNCYUnicycive Therapeutics Inc
07/09/202322h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
07/09/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:UNCYUnicycive Therapeutics Inc
06/09/202313h03GlobeNewswire Inc.Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhDNASDAQ:UNCYUnicycive Therapeutics Inc
29/08/202313h03GlobeNewswire Inc.Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight SeriesNASDAQ:UNCYUnicycive Therapeutics Inc
14/08/202323h36GlobeNewswire Inc.Unicycive Announces Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:UNCYUnicycive Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:UNCY

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
EU
BNP
BNP Paribas
EU
ACA
Credit Agricole
NYSE
MRK
Merck
EU
RI
Pernod Ricard
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
EU
AI
Air Liquide
NASDAQ
GOOGL
Alphabet
EU
CS
Axa
EU
VK
Vallourec
EU
ORA
Orange
NYSE
KO
Coca Cola
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés